I've raised this point with a couple posters, but I think it's a good question for the board. If this is doable, and I don't know that it is; does NGIO absorb GNBT, if and when it is uplisted. I think we all agree that NGIO's prospects for uplisting are better than GNBT's. New company, no hair on it, appears it will have adequate funding and share price. Yet look how long this is taking. I can't see any quick path to uplisting for GNBT. Lots of hair on it; pitiful pps, funding possibly, but it's taking forever, and COVID time delays. What do you guys and gals think?
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links